Dr Reddy's launches allergy relief tablets in the US

The allergy drug has been approved by the United States Food & Drug Administration

Hyderabad-based pharmaceutical company Dr Reddy’s Laboratories has launched over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride extended release tablets 60 mg / 120 mg.

The allergy relief and nasal decongestant tablets are bioequivalent generic version of Allegra-D 12 Hour. The abbreviated new drug application of Dr Reddy’s has been approved by the United States Food & Drug Administration (USFDA), the company stated in a press release here on Thursday.

The Allegra-D 12 Hour brand has US sales of approximately $ 49.8 million for the latest 52 weeks ending October 6, 2014.